Savolitinib and durvalumab for metastatic papillary kidney cancer
In a phase 2 clinical trial, patients with metastatic papillary [...]
Savolitinib plus durvalumab for papillary kidney cancer
In a recent study published in the Journal of Clinical [...]
EIKCS 2021: Biomarkers for kidney cancer
Dr Thomas Powles from St Barts Hospital, London spoke about [...]
ASCO GU 2021: Comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for advanced papillary kidney cancer
A gene called MET codes for a protein called MET [...]
Savolitinib shows promise in first-in-human phase 1 study in solid tumours
Results from a first-in-human phase 1 study of savolitinib in [...]
Current treatment of advanced papillary renal cell carcinoma
Despite significant improvements in the treatment outcomes of clear cell [...]
